Novo Nordisk launches smart insulin pen in Denmark

Pharmaceutical company Novo Nordisk sends its smart insulin pens Novopen 6 and Novo Pen Echo Plus on the Danish market two months after they were launched in Sweden.

Photo: Stine Tidsvilde

Two months after Novo Nordisk relaunched the firm's smart insulin pens Novopen 6 and Echo Plus in Sweden, they've made their way to the Danish market, according to a Danish press announcement from Novo Nordisk.

"Diabetes is a lifelong companion which develops over the years which means you have to constantly get treatment for it. In this case, it can be an advantage that by using the new smart pens you can optimize medical treatment for each individual patient," states Novo Nordisk Medical Director Troels Munk Jensen in the statement.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs